3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Brain - Cancer -

Allergies may protect against brain cancer

Brain • • CancerNov 02, 07

A history of allergies may reduce the risk of a particular type of brain tumor called glioma, investigators report in the Journal of the National Cancer Institute.

Little is known about what causes glioma, note Dr. Eleni Linos, of Harvard School of Public Health, Boston, Massachusetts, and colleagues. “Atopic (allergic) diseases are on the rise in western populations, with increasing interest in their long-term health consequences,” they point out. “An inverse association between (allergy) and the risk of glioma has been observed.”

To investigate further, the researchers conducted a systematic review and pooled analysis of published studies that quantified the association between asthma, eczema, or allergy and a medically confirmed diagnosis of glioma or another type of brain tumor called meningioma.

A total of eight studies with 3,450 patients diagnosed with glioma and 1,070 patients with meningioma were included in the analysis.

They found that the relative risk of glioma was markedly lower in those with a history of allergy, asthma or eczema, compared to those with no history of allergic disease.

There was no overall significant association between allergy and meningioma. However, the information on this disease was limited.

There are several possible reasons why allergies might offer protection against brain cancer. Immune factors that are involved in or predispose people to allergies might play a role. It is also possible that medications used to treat these conditions could offer some protection. Other factors including some that are not involved with the immune system may also affect the risk.

SOURCE: Journal of the National Cancer Institute, October 17, 2007.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Repairing the cerebral cortex: It can be done
  Clinical trial suggests combination therapy is best for low-grade brain tumors

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site